LONA Q2 2024 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena

LONALeonaBio, Inc.

$26M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$242,000

Operating Income

-$28M

Net Income

-$27M

EPS (Diluted)

$-7.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$111M

Total Liabilities

$28M

Stockholders' Equity

$83M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$242,000	$0	—
Operating Income	-$28M	-$32M	+11.4%
Net Income	-$27M	-$30M	+9.3%